| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/22/2002 | WO2000014200A9 Essential bacterial genes and their use |
| 08/22/2002 | US20020116724 Nucleotide sequences codingolypeptide for use in the diagnosis and prevention of psoriasis and venous ulcers |
| 08/22/2002 | US20020115848 IBD-associated microbial nucleic acid molecules |
| 08/22/2002 | US20020115843 Nucleotide sequences for use in the treatment of viral diseases, hypertension and coagulation defects |
| 08/22/2002 | US20020115829 Pathogenic escherichia coli associated protein |
| 08/22/2002 | US20020115724 Methods and agents for inhibiting protein aging |
| 08/22/2002 | US20020115614 Inhibition of complement action |
| 08/22/2002 | US20020115610 Isolated polypeptides that stimulate gastrointestinal smooth muscle contraction, including human; ionotropic agents; enhanced gastrointestinal motility; identifying a prokineticin receptor ligand; calcium mobilization |
| 08/22/2002 | US20020115607 Involved in the pathogenesis of Huntington's Disease, Parkinson's Disease, dementia and Alzheimer's Disease (AD); diagnosis, drug screening, animal models |
| 08/22/2002 | US20020115606 Involved in the pathogenesis of Huntington's Disease, Parkinson's Disease, dementia and Alzheimer's Disease (AD); modulating, in a cell, a protein complex between PN7740 and ligand Fe65 or PSD95 |
| 08/22/2002 | US20020115598 Method for the improvement of neuronal regeneration |
| 08/22/2002 | US20020115214 Induction of lymphocytes; obtain cells, activate cells, incubate with activator, monitor lymphocyte proliferation |
| 08/22/2002 | US20020115203 Proteins for use in the treatment infectious, cancers and autoimmune disease |
| 08/22/2002 | US20020115187 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of arthritis and cancer; for use as antiscarring agent |
| 08/22/2002 | US20020115186 Peptide for use in the diagnosis, prevention, and treatment of inflammation, cancer, arteriosclerosis and degenerative defects |
| 08/22/2002 | US20020115183 Enzymatic protien for us ein prevention of tumor metastasis |
| 08/22/2002 | US20020115176 Polypeptide for use in the diagnosis and treatment of asthma, and respiratory disorders |
| 08/22/2002 | US20020115175 Enzymatic polypeptide for use in the treatment of inflammation, reperfusion injury, viral diseases, allergies, infections, pain, autoimmune,cardiovascular, nervous system, kidney, urogenital, sexual, kidney disorders |
| 08/22/2002 | US20020115167 Isolation of drosophila and human polynucleotides encoding PAR-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 08/22/2002 | US20020115166 Peptide for use in the treatment of pancreatic defects |
| 08/22/2002 | US20020115156 Connective tissue growth factor for use in the treatment of cancer, fibrotic defects and atherosclerosis; for use as wound healing agents |
| 08/22/2002 | US20020115154 Trail receptors, nucleic acids encoding the same, and methods of use thereof |
| 08/22/2002 | US20020115151 Human defensin polypeptide Def-X, genomic DNA and cDNA, composition containing them and applications to diagnosis and to therapeutic treatment |
| 08/22/2002 | US20020115145 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/22/2002 | US20020115143 Expression vector coding immunoglobulin for use in the of infections and cancer |
| 08/22/2002 | US20020115139 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of lung tumors |
| 08/22/2002 | US20020115138 Nucleotide sequences coding transport protein for use in treat ment of tumors |
| 08/22/2002 | US20020115135 Synapse related glycoproteins |
| 08/22/2002 | US20020115134 Generation of preferential antibodies; fragment antibody, purify antibody and remove antibody adduct, incubate with solid support, recover antibodies |
| 08/22/2002 | US20020115119 Protein-protein interactions in neurodegenerative diseases |
| 08/22/2002 | US20020115114 Detecting modulators of kinase activity; obtain enzymatic polypeptide, incubate with modulator, monitor binding activity of kinases |
| 08/22/2002 | US20020115113 Conductive polymer matrix for use in the efficient isolation of preferential stem cells |
| 08/22/2002 | US20020115112 Neutrokine-alpha and Neutrokine-alpha splice variant |
| 08/22/2002 | US20020115108 Enzymes having high temperature polymerase activity and methods of use thereof |
| 08/22/2002 | US20020115083 Detecting preferential nucleotide sequences in sample; obtain messenger ribonucleic acid sequences, translate, recover polypeptide, incubate with target molecule, evaluate activity of protein |
| 08/22/2002 | US20020115081 Nucleotide sequences coding polypeptide for use in the the treatament of cardiovasculAR disorders |
| 08/22/2002 | US20020115078 Nucleotide sequences coding polypeptide for use in the treatment and prevention of bacterial infections |
| 08/22/2002 | US20020115068 Matrix screening method |
| 08/22/2002 | US20020115065 Differentially expressed epitopes and uses thereof |
| 08/22/2002 | US20020115064 Peptide or protein for use in the diagnosis, treatment or prophylaxis of viral disease |
| 08/22/2002 | US20020114812 Preparing cells as cancer therapy for administration to a subject with cancer comprising culturing cells in the presence of an macrophage migration inhibitory factor antagonist |
| 08/22/2002 | US20020114811 Contacting body fluid from mammal with antibody which binds to human aspartyl (asparaginyl) beta-hydroxylase (HAAH) polypeptide under conditions sufficient to form antigen-antibody complex and detecting complex |
| 08/22/2002 | US20020114810 Diagnosis and treatment of malignant neoplasms statement as to federally sponsored research |
| 08/22/2002 | US20020114807 Administering drug comprising a substance that specifically recognizes extracellular domain of signal regulatory proteins and that inhibits functioning of pathologic myeloid cells |
| 08/22/2002 | US20020114805 Methods of treating myelodysplastic syndrome with anti-TNF antibodies |
| 08/22/2002 | US20020114804 Administering agent capable of inhibiting signalling mediated by beta 1 integrin cell surface receptor of leukocyte cells in amount effective to enhance migration of leukocyte cells into fibrin to reach and kill bacteria |
| 08/22/2002 | US20020114802 Oral immunoglobulin treatment for inflammatory bowel disease |
| 08/22/2002 | US20020114801 Heparanase specific molecular probes and their use in research and medical applications |
| 08/22/2002 | US20020114799 Protein-protein interactions in neurodegenerative diseases |
| 08/22/2002 | US20020114787 Tolerance to natural antibody antigens |
| 08/22/2002 | CA2439129A1 Novel cellular adhesion molecule of activated leukocyte |
| 08/22/2002 | CA2438658A1 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent |
| 08/22/2002 | CA2438219A1 Sequences involved in phenomena of tumour suppression, tumour reversion apoptosis and/or virus resistance and their use as medicines |
| 08/22/2002 | CA2438215A1 Putative human enzymes |
| 08/22/2002 | CA2438125A1 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof |
| 08/22/2002 | CA2437873A1 Neurotonin and use thereof |
| 08/22/2002 | CA2437811A1 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/22/2002 | CA2437246A1 Novel human poly(a)polymerase gamma (pap gamma) |
| 08/22/2002 | CA2436713A1 Proteins and nucleic acids encoding same |
| 08/22/2002 | CA2436259A1 Compounds effecting neuron remodeling and assays for same |
| 08/22/2002 | CA2433843A1 Molecules for disease detection and treatment |
| 08/22/2002 | CA2432364A1 Bax-responsive genes for drug target identification in yeast and fungi |
| 08/22/2002 | CA2430726A1 Isolated human transporter proteins, nucleic acid molecules encoding them and uses thereof |
| 08/22/2002 | CA2427112A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 08/21/2002 | EP1233060A2 Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same |
| 08/21/2002 | EP1233026A1 Antibody against rat postacrosome reaction sperm and utilization thereof |
| 08/21/2002 | EP1233023A1 Transcription factor and dna thereof |
| 08/21/2002 | EP1232755A2 Anti-HIV agents |
| 08/21/2002 | EP1232396A2 Assay of isomerised and/or optically inverted proteins |
| 08/21/2002 | EP1232394A1 Sandwich immunoassay and monoclonal antibodies for comp, cartillage oligomeric matrix protein |
| 08/21/2002 | EP1232392A1 Improved method for the detection of acid resistant microorganisms in a stool |
| 08/21/2002 | EP1232268A2 Cytochrome p450 oxygenases and their uses |
| 08/21/2002 | EP1232266A2 Polypeptides and nucleic acids encoding same |
| 08/21/2002 | EP1232265A2 G-protein coupled receptor htogh35 |
| 08/21/2002 | EP1232264A2 Human fgf-21 gene and gene expression products |
| 08/21/2002 | EP1232263A2 Polypeptides and nucleic acids encoding same |
| 08/21/2002 | EP1232262A2 Recombinant gelatin in vaccines |
| 08/21/2002 | EP1232260A2 Polymorphisms in the human mdr-1 gene and applications thereof |
| 08/21/2002 | EP1232246A1 A human normal counterpart of cd4+ cd56+ cutaneous neoplasm |
| 08/21/2002 | EP1232186A2 Antibody to human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin |
| 08/21/2002 | EP1232185A2 Methods of inhibiting metastasis |
| 08/21/2002 | EP1232184A1 Antibody against the human toll-like receptor-2 (tlr2) and uses thereof |
| 08/21/2002 | EP1232179A1 15 human secreted proteins |
| 08/21/2002 | EP1232178A2 Compositions and methods for regulating tumor-associated antigen expression |
| 08/21/2002 | EP1232177A2 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 08/21/2002 | EP1232176A1 Tumour suppressor factor |
| 08/21/2002 | EP1232167A1 Synthetic oligomannosides, preparation and uses thereof |
| 08/21/2002 | EP1231944A2 Targeted delivery of therapeutic and diagnostic moieties |
| 08/21/2002 | EP1231937A2 Tr3-specific binding agents and methods for their use |
| 08/21/2002 | EP1231930A1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS |
| 08/21/2002 | EP1231836A2 Human ex vivo immune system |
| 08/21/2002 | EP0980251B1 Tissue factor for influencing blood vessel formation |
| 08/21/2002 | EP0771192B1 Use of anti-vegf agents in the treatment of endometriosis |
| 08/21/2002 | EP0567577B1 Nucleotide sequences coding for the murine adrenergenic beta 3 receptor and applications thereof |
| 08/21/2002 | CN1365392A Drosophila recombination-associated protein and methods for use |
| 08/21/2002 | CN1365387A Method of detecting trichlothecene mycotoxins and reagent thereof |
| 08/21/2002 | CN1364904A New poypeptide-human glucosamino-6-phosphoisomerase 25.74 and polynucleotide for encoding such polypeptide |
| 08/21/2002 | CN1364903A New polypeptide-human glucosamino-6-phosphoisomerase 11.99 and polynucleotide for encoding such polypeptide |
| 08/21/2002 | CN1364902A New polypeptide-amidase family protein 16.06 and polynucleotide for encoding such polypeptide |
| 08/21/2002 | CN1364901A New polypeptide-arginase 8.91 and polynucleotide for encoding such polypeptide |